A novel combination prostate cancer therapy has been approved by the US Food and Drug Administration. The new treatment combines two Pfizer-produced cancer drugs, Xtandi (also...
Scientists have moved a step closer to genetically personalised prostate cancer screening. The most common assessment test for the cancer, which mainly affects men over the...
Scientists researching an ‘ancient virus’ treatment for metastatic prostate cancer have been awarded $1.7 million by the US Department for Defense. Oncology expert Charles Spruck’s laboratory...
A new drug combo has been shown to boost metastasis-free survival by 58% in prostate cancer patients at high risk of biochemical recurrence. Astellas Pharma and...
A seven-figure funding boost to further develop a prostate cancer test could help save thousands of lives, its developers say. Despite being the most common malignancy...
Stool samples could soon help doctors spot early signs of pancreatic cancer, according to a new study. The findings are published in the journal, Gut. The...
